Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07342400 · ClinicalTrials.gov registry record · NA
A Clinical Study to Assess Histological Changes From Treatment of Poly L-lactic Acid Biostimulator on Women at Various Menopausal Stages
A NA study of Menopausal Women and Cheek Wrinkles, sponsored by Galderma R&D.
- Recruiting
- Registry status
- NA
- Development phase
- 40
- Enrollment target
- 2
- Study locations
NCT07342400 is a NA study of Menopausal Women and Cheek Wrinkles that is actively recruiting participants, run by Galderma R&D. The registered enrollment target is 40 participants. The trial reports 2 study locations across 2 states.
The verdict
NCT07342400, a NA study of Menopausal Women and Cheek Wrinkles, is actively recruiting participants, sponsored by Galderma R&D.
- RECRUITING
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
- 2
- Study locations
Study Summary
To assess protein expression stimulated by poly L-lactic acid (PLLA) via punch biopsy at each follow-up visits compared to Baseline.
Conditions Studied
Interventions
- DEVICE Sculptra®
Study Locations (2)
Florida
- Miami Dermatology & Laser Institute - Miami
New York
- Day Dermatology & Aesthetics - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2025-08-12 |
| Est. Completion | 2026-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07342400
The ClinicalTrials.gov registry entry for NCT07342400 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Galderma R&D, which has 158 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Menopausal Women appearing as the primary indexed condition, and to 1 intervention - of which Sculptra® is the first listed.
NCT07342400 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Florida, New York.
Frequently Asked Questions
What is clinical trial NCT07342400 about?
NCT07342400 is a clinical study titled "A Clinical Study to Assess Histological Changes From Treatment of Poly L-lactic Acid Biostimulator on Women at Various Menopausal Stages". To assess protein expression stimulated by poly L-lactic acid (PLLA) via punch biopsy at each follow-up visits compared to Baseline.
What is the current status of trial NCT07342400?
This trial is currently recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2025-08-12. Estimated completion is 2026-11.
What conditions does trial NCT07342400 study?
This clinical trial studies the following conditions: Menopausal Women, Cheek Wrinkles.
What interventions are being tested in trial NCT07342400?
The interventions under investigation include: Sculptra® (DEVICE).
Who is sponsoring clinical trial NCT07342400?
This trial is sponsored by Galderma R&D, which has 158 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07342400 being conducted?
This trial has 2 study locations across Florida, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Menopausal Women
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.